Advertisement

Isothiazolinones

  • Jakob Ferløv Schwensen
  • Jeanne Duus Johansen
Living reference work entry

Abstract

Isothiazolinones are used in cosmetic and chemical substances for occupational use and possess bacteriostatic and fungiostatic activity. Isothiazolinones are potent contact allergens. The use of the isothiazolinone methylchloroisothiazolinone (MCI) in 3:1 combination with methylisothiazolinone (MI) (MCI/MI) resulted in the 1980s in high prevalence rates of contact allergy to MCI/MI across the EU. This rapid increase in new cases of MCI/MI contact allergy instigated a restriction of MCI/MI to 15 ppm that subsequently resulted in decreasing prevalence rates of contact allergy to MCI/MI in the EU. Later, around the millennium, MI was introduced as a single preservative in chemical substances for occupational use, and in 2005 and onward, MI was introduced in cosmetic products as a single preservative. The use of MI has resulted in an unprecedented steep increase in new cases of contact allergy to MI on the European continent, the US, Asia, and Australia. In many countries, the prevalence rates of MI exceed 7–10%. These two epidemics have mainly been driven by use of MCI/MI and MI in cosmetic products, but both are as well important allergens in the work environment. Occupations at special risk for MCI/MI or MI sensitization are painters, blacksmiths, machine operators, cosmetologists, and tile setters.

Other isothiazolinones, e.g., benzisothiazolinone (BIT) and octylisothiazolione (OIT), are only used in industrial products and non-cosmetic consumer products such as paints and leather products and also pose a problem in special occupations.

Keywords

Methylisothiazolinone Benzisothiazolinone Octylisothiazolinone Risk occupations 

References

  1. Aalto-Korte K, Suuronen K (2017) Patterns of concomitant allergic reactions in patients suggest cross-sensitization between octylisothiazolinone and methylisothiazolinone. Contact Dermatitis 77:385.  https://doi.org/10.1111/cod.12855. [Epub ahead of print]CrossRefPubMedGoogle Scholar
  2. Aalto-Korte K, Ackermann L, Henriks-Eckerman ML, Valimaa J, Reinikka-Railo H, Leppanen E, Jolanki R (2007) 1,2-benzisothiazolin-3-one in disposable polyvinyl chloride gloves for medical use. Contact Dermatitis 57:365–370CrossRefPubMedGoogle Scholar
  3. Aerts O, Cattaert N, Lambert J, Goossens A (2013) Airborne and systemic dermatitis, mimicking atopic dermatitis, caused by methylisothiazolinone in a young child. Contact Dermatitis 68(4):250–251CrossRefPubMedGoogle Scholar
  4. Aerts O, Baeck M, Constandt L, Dezfoulian B, Jacobs MC, Kerre S, Lapeere H, Pierret L, Wouters K, Goossens A (2014) The dramatic increase in the rate of methylisothiazolinone contact allergy in Belgium: a multicentre study. Contact Dermatitis 71:41–48CrossRefPubMedGoogle Scholar
  5. Aerts O, Meert H, Romaen E, Leysen J, Matthieu L, Apers S, Lambert J, Goossens A (2016) Octylisothiazolinone, an additional cause of allergic contact dermatitis caused by leather: case series and potential implications for the study of cross-reactivity with methylisothiazolinone. Contact Dermatitis 75:276–284CrossRefPubMedGoogle Scholar
  6. Alomar A (1981) Contact dermatitis from benzisothiazolone in cutting oils. Contact Dermatitis 7:155–156CrossRefPubMedGoogle Scholar
  7. Amsler E, Aerts O, Raison-Peyron N, Debons M, Milpied B, Giordano-Labadie F, Waton J, Ferrier-Le Bouëdec MC, Lartigau I, Pecquet C, Assier H, Avenel-Audran M, Bernier C, Castelain F, Collet E, Crépy MN, Genillier N, Girardin P, Pralong P, Tetart F, Vital-Durand D, Soria A, Barbaud A (2017) Dermatology Allergy Group (DAG) of the French Society of Dermatology. Airborne allergic contact dermatitis caused by isothiazolinones in water-based paints: a retrospective study of 44 cases. Contact Dermatitis 77:163.  https://doi.org/10.1111/cod.12795. [Epub ahead of print]CrossRefPubMedGoogle Scholar
  8. Basketter D, Wright Z, Walters T, Boman A, Lidén C (2003) Biocides: characterization of the allergenic hazard of methylisothiazolinone. Cutan Ocul Toxicol 22:187–199CrossRefGoogle Scholar
  9. Bjorkner B, Bruze M, Dahlquist I, Fregert S, Gruvberger B, Persson K (1986) Contact allergy to the preservative Kathon CG. Contact Dermatitis 14:85–90CrossRefPubMedGoogle Scholar
  10. Breuer K, Uter W, Geier J (2015) Epidemiological data on airborne contact dermatitis - results of the IVDK. Contact Dermatitis 73:239–247CrossRefPubMedGoogle Scholar
  11. Bruze M, Gruvberger B, Persson K (1987) Contact allergy to a contaminant in Kathon CG in the guinea pig. Derm Beruf Umwelt 35:165–168PubMedGoogle Scholar
  12. Bruze M, Gruvberger B, Agrup G (1988) Sensitization studies in the guinea pig with the active ingredients of Euxyl K 400. Contact Dermatitis 18:37–39CrossRefPubMedGoogle Scholar
  13. Bruze M, Engfeldt M, Gonçalo M, Goossens A (2013) Recommendation to include methylisothiazolinone in the European baseline patch test series – on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis 69(5):263–270CrossRefPubMedGoogle Scholar
  14. Bruze M, Goossens A, Isaksson M (2014) Recommendation to increase the test concentration of methylchloroisothiazolinone/methylisothiazolinone in the European baseline patch test series - on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis 71(1):35–40CrossRefPubMedGoogle Scholar
  15. Bruze M, Uter W, Gonçalo M, Lepoittevan J-P, Diepgen T, Orton D (2015) Incompetence and failure to regulate methylisothiazolinone. Contact Dermatitis 72:353–354CrossRefGoogle Scholar
  16. Cronin E, Hannuksela M, Lacapelle JM, Maibach H, Malten K, Meninghini C (1988) Frequency of sensitisation to the preservative Kathon CG. Contact Dermatitis 18:274–279CrossRefPubMedGoogle Scholar
  17. Damstra RJ, Van Vlotten WA, Van Ginkel CJ (1992) Allergic contact dermatitis from the preservative 1,2-benzisothiazolin-3-one (1,2-BIT; Proxel): a case report, its prevalence in those occupationally at risk and in the general dermatological population, and its relationship to allergy to its analogue Kathon CG. Contact Dermatitis 27:105–109CrossRefPubMedGoogle Scholar
  18. Debeuckelaere C, Moussallieh FM, Elbayed K, Namer IJ, Berl V, Giménez-Arnau E, Lepoittevin J-P (2016) In situ chemical behaviour of methylisothiazolinone (MI) and methylchloroisothiazolinone (MCI) in reconstructed human epidermis: a new approach to the cross-reactivity issue. Contact Dermatitis 74:159–167CrossRefPubMedGoogle Scholar
  19. de Groot AC, Herxheimer A (1989) Isothiazolinone preservative: cause of a continuing epidemic of cosmeticdermatitis. Lancet 1:314–316CrossRefPubMedGoogle Scholar
  20. Dias M, Lamarao P, Vale T (1992) Occupational contact allergy to 1,2-benzisothiazolin-3-one in the manufacture of air fresheners. Contact Dermatitis 27:205–207CrossRefPubMedGoogle Scholar
  21. European Chemicals Agency (ECHA) (2011) Guidance on labelling and packaging in accordance with regulation (EC) No. 1272/2008, Reference ECHA-11-G-04-EN 2011 April. Available at: https://echa.europa.eu/documents/10162/13562/clp_labelling_en.pdf. Last accessed 31 July 2017
  22. European Chemicals Agency (ECHA) (2016) Guidance on labelling and packaging in accordance with regulation (EC) No. 1272/2008, Reference ECHA-16- G-05- EN 2016 April. Available at: https://echa.europa.eu/documents/10162/23036412/clp_labelling_en.pdf/89628d94-573a-4024-86cc-0b4052a74d65. Last accessed 31 July 2017
  23. European Chemicals Agency (ECHA RAC) (2016) Committee for risk assessment, RAC. Opinion, proposing harmonised classification and labelling at EU level of 2-methylisothiazol- 3(2H)-one (ISO), Adopted 10 March 2016. Available at: https://echa.europa.eu/documents/10162/b32e77aa-b720-4f66-ad16-a413dadf1631. Last accessed 31 July 2017
  24. European Commission (EC). Official journal of the European Union. Regulations. Commission regulation (EU) 2016/1198 of 22 July 2016 amending Annex V to Regulation (EC) No 1223/2009 of the European Parliament and of the council on cosmetic products. Published 23 July 2016. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R1198&from=EN. Last accessed 1 Aug 2017
  25. Fischer T, Bohlin S, Edling C, Rystedt I, Wieslander G (1995) Skin disease and contact sensitivity in house painters using water-based paints, glues and putties. Contact Dermatitis 32:39–45CrossRefPubMedGoogle Scholar
  26. Flyvholm MA (2005) Preservatives in registered chemical products. Contact Dermatitis 53:27–32CrossRefPubMedGoogle Scholar
  27. Fransway AF (1988) Sensitivity to Kathon CG findings in 365 consecutive patients. Contact Dermatitis 19:342–347CrossRefPubMedGoogle Scholar
  28. Freeman S (1984) Allergic contact dermatitis due to 1,2-benzisothiazolin-3-one in gum arabic. Contact Dermatitis 11:146–149CrossRefPubMedGoogle Scholar
  29. Friis UF, Menné T, Flyvholm MA, Bonde JP, Lepoittevin JP, Le Coz CJ, Johansen JD (2014) Isothiazolinones in commercial products at Danish workplaces. Contact Dermatitis 71(2):65–74CrossRefPubMedGoogle Scholar
  30. Frosch P, Schulze-Dirks A (1987) Kontaktallergie uaf Kathon CG. Hautarzt 38:422–425PubMedGoogle Scholar
  31. Fuchs T (1986) Aktuelle Kontaktallergene und ihre Perspektiven. Med Welt 37:1305–1307Google Scholar
  32. Gallo R, Signori A, Gervasio S, Riva S, Parodi A (2016) Methylisothiazolinone contact allergy – are rinse-off cosmetics and household products relevant sources of exposure? Contact Dermatitis 75:319–321CrossRefPubMedGoogle Scholar
  33. Gameiro A, Coutinho I, Ramos L, Gonçalo M (2014) Methylisothiazolinone: second ‘epidemic’ of isothiazolinone sensitization. Contact Dermatitis 70:242–243CrossRefPubMedGoogle Scholar
  34. García-Gavín J, Vansina S, Kerre S, Naert A, Goossens A (2010) Methylisothiazolinone, an emerging allergen in cosmetics? Contact Dermatitis 63(2):96–101CrossRefPubMedGoogle Scholar
  35. Garcia-Hidalgo E, Sottas V, Von Goetz N, Hauri U, Bogdal C, Hungerbuhler K (2017) Occurrence and concentrations of isothiazolinones in detergents and cosmetics in Switzerland. Contact Dermatitis 76:96–106CrossRefPubMedGoogle Scholar
  36. Geier J, Schnuch A (1996) No cross-reactivity between MCI/MI, benzisothiazolinone and octylisothiazolinone. Contact Dermatitis 34:148–149CrossRefPubMedGoogle Scholar
  37. Geier J, Lessmann H, Schnuch A, Uter W (2012) Recent increase in allergic reactions to methylchloroisothiazolinone/methylisothiazolinone: is methylisothiazolinone the culprit? Contact Dermatitis 67:334–341CrossRefPubMedGoogle Scholar
  38. Geier J, Lessmann H, Schnuch A, Uter W (2015) Concomitant reactivity to methylisothiazolinone, benzisothiazolinone, and octylisothiazolinone. International Network of Departments of Dermatology data, 2009–2013. Contact Dermatitis 72:337–339CrossRefPubMedGoogle Scholar
  39. Gonçalo M, Goossens A (2013) Whilst Rome burns: the epidemic of contact allergy to methylisothiazolinone. Contact Dermatitis 68:257–258CrossRefPubMedGoogle Scholar
  40. Gruvberger B, Bruze M, Almgren G (1998) Occupational dermatoses in a plant producing binders for paints and glues. Contact Dermatitis 38:71–77CrossRefPubMedGoogle Scholar
  41. Hannuksela M (1987) Rapid increase in contact allergy to Kathon CG in Finland. Contact Dermatitis 17:299–302CrossRefGoogle Scholar
  42. Hardcastle NJ, Gawkrodger DJ (2005) Occupational contact dermatitis to 2-benzisothiazolin-3-one and 5-chloro-2-methylisothiazolin-3-one/2-methylisothiazolin-3-one in paint manufactures. Contact Dermatitis 53:115–116CrossRefPubMedGoogle Scholar
  43. Hjorth N, Roed-Petersen J (1986) Patch test sensitivity to Kathon CG. Contact Dermatitis 14:155–157CrossRefPubMedGoogle Scholar
  44. Hosteing S, Meyer N, Waton J, Barbaud A, Bourrain JL, Raison-Peyron N, Felix B, Milpied-Homsi B, Ferrier Le Bouedec MC, Castelain M, Vital-Durand D, Debons M, Collet E, Avenel-Audran M, Mathelier-Fusade P, Vermeulen C, Assier H, Gener G, Lartigau-Sezary I, Catelain-Lamy A, Giordano-Labadie F (2014) Outbreak of contact sensitization to methylisothiazolinone: an analysis of French data from the REVIDAL-GERDA network. Contact Dermatitis 70:262–269CrossRefPubMedGoogle Scholar
  45. Isaksson M, Persson L (2015) “Mislabelled” make-up remover wet wipes as a cause of severe, recalcitrant facial eczema. Contact Dermatitis 73:56–59CrossRefPubMedGoogle Scholar
  46. Isaksson M, Gruvberger B, Bruze M (2004) Occupational contact allergy and dermatitis from methylisothiazolinone after contact with wallcovering glue and after a chemical burn from a biocide. Dermatitis 15:201–205PubMedGoogle Scholar
  47. Isaksson M, Bruze M, Gruvberger B (2008) Cross-reactivity between methylchloroisothiazolinone/methylisothiazolinone, methylisothiazolinone, and other isothiazolinones in workers at a plant producing binders for paints and glues. Contact Dermatitis 58:60–62CrossRefPubMedGoogle Scholar
  48. Isaksson M, Ale I, Andersen KE, Elsner P, Goh CL, Goossens A, Jerajani H, Matsunaga K, McFadden J, Bruze M (2017) Multicenter patch testing with methylisothiazolinone and methylchloroisothiazolinone/methylisothiazolinone within the International Contact Dermatitis Research Group. Dermatitis 28(3):210–214.  https://doi.org/10.1097/DER.0000000000000272CrossRefPubMedGoogle Scholar
  49. Johansen JD, Aalto-Korte K, Agner T, Andersen KE, Bircher A, Bruze M, Cannavo A, Giménez- Arnau A, Gonçalo M, Goossens A, John SM, Lidén C, Lindberg M, Mahler V, Matura M, Rustemeyer T, Serup J, Spiewak R, Thyssen JP, Vigan M, White IR, Wilkinson M, Uter W (2015) European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice. Contact Dermatitis 73:195–221CrossRefPubMedGoogle Scholar
  50. Johnston GA, Contributing Members of the British Society for Cutaneous Allergy (BSCA) (2014) The rise in prevalence of contact allergy to methylisothiazolinone in the British Isles. Contact Dermatitis 70:238–240CrossRefPubMedGoogle Scholar
  51. Lammintausta K, Aalto-Korte K, Ackerman L, Alanko K, Berry P, Hasan T, Kaminska R, Korhonen L, Laukkanen A, Liippo J, Pesonen M, Rantanen T, Riekki R, Suuronen K (2014) An epidemic of contact allergy to methylisothiazolinone in Finland. Contact Dermatitis 70:184–185CrossRefPubMedGoogle Scholar
  52. Lundov MD, Thyssen JP, Zachariae C, Johansen JD (2010) Prevalence and cause of methylisothiazolinone contact allergy. Contact Dermatitis 63:164–167CrossRefPubMedGoogle Scholar
  53. Lundov MD, Opstrup MS, Johansen JD (2013) Methylisothiazolinone contact allergy – growing epidemic. Contact Dermatitis 69(5):271CrossRefPubMedGoogle Scholar
  54. Lundov MD, Kolarik B, Bossi R, Gunnarsen L, Johansen JD (2014) Emission of isothiazolinones from water-based paints. Environ Sci Technol 48(12):6989–6994CrossRefPubMedGoogle Scholar
  55. Madsen JT, Broesby-Olsen S, Andersen KE (2014) Undisclosed methylisothiazolinone in an ultrasound gel causing occupational allergic contact dermatitis. Contact Dermatitis 71:312–313CrossRefPubMedGoogle Scholar
  56. Madsen JT, Andersen KE, Nielsen DT, Hvid L, El-Houri RB, Christensen LP (2016) Undisclosed presence of methylisothiazolinone in ‘100% natural’ Konjac(R) sponge. Contact Dermatitis 75:308–309CrossRefPubMedGoogle Scholar
  57. Magnano M, Silvani S, Vincenzi C, Nino M, Tosti A (2009) Contact allergens and irritants in household washing and cleaning products. Contact Dermatitis 61:337–341CrossRefPubMedGoogle Scholar
  58. Meding B, Ahman M, Karlberg AT (1996) Skin symptoms and contact allergy in woodwork teachers. Contact Dermatitis 34:185–190CrossRefPubMedGoogle Scholar
  59. Menné T, Hjorth N (1988) Kathon CG reactivity in 1396 consecutively patch tested patients in the Copenhagen area. Contact Dermatitis 19:260–262CrossRefPubMedGoogle Scholar
  60. Meysman T, Goossens A (2017) Occupational allergic contact dermatitis caused by benzisothiazolinone in printing ink and soap. Contact Dermatitis 76:51–53CrossRefPubMedGoogle Scholar
  61. Mose AP, Lundov MD, Zachariae C, Menné T, Veien NK, Laurberg G, Kaaber K, Avnstorp C, Andersen KE, Paulsen E, Mortz CG, Sommerlund M, Danielsen A, Thormann J, Kristensen O, Kristensen B, Andersen BL, Vissing S, Nielsen NH, Johansen JD (2012) Occupational contact dermatitis in painters: an analysis of patch test data from the Danish Contact Dermatitis Group. Contact Dermatitis 67:293–297CrossRefPubMedGoogle Scholar
  62. Mose AP, Frost S, Ohlund U, Andersen KE (2013) Allergic contact dermatitis from octylisothiazolinone. Contact Dermatitis 69:49–52CrossRefPubMedGoogle Scholar
  63. Reinhard E, Waeber R, Niederer M, Maurer T, Maly P, Scherer S (2001) Preservation of products with MCI/MI in Switzerland. Contact Dermatitis 45:257–264CrossRefPubMedGoogle Scholar
  64. Roberts DL, Messenger AG, Summerly R (1981) Occupational dermatitis due to 1,2-benzisothiazolin-3-one in the pottery industry. Contact Dermatitis 7:145–147CrossRefPubMedGoogle Scholar
  65. Sanz-Gallén P, Planas J, Martinez P, Giménez-Arnau JM (1992) Allergic contact dermatitis due to 1,2-benzisothiazolin-3-one in paint manufacture. Contact Dermatitis 27:271–272CrossRefPubMedGoogle Scholar
  66. Schnuch A, Mildau G, Kratz EM, Uter W (2011) Risk of sensitization to preservatives estimated on the basis of patch test data and exposure, according to a sample of 3541 leave-on products. Contact Dermatitis 65:167–174CrossRefPubMedGoogle Scholar
  67. Schwensen JF, Thyssen JP (2016) Contact allergy to preservatives–is the European Commission a commendable risk manager? Cosmetics 3:29CrossRefGoogle Scholar
  68. Schwensen JF, Menné T, Andersen KE, Sommerlund M, Johansen JD (2014) Occupations at risk of developing contact allergy to isothiazolinones in Danish contact dermatitis patients: results from a Danish multicentre study (2009–2012). Contact Dermatitis 71:295–302CrossRefPubMedGoogle Scholar
  69. Schwensen JF, Lundov MD, Bossi R, Banerjee P, Giménez-Arnau E, Lepoittevin JP, Lidén C, Uter W, Yazar K, White IR, Johansen JD (2015a) Methylisothiazolinone and benzisothiazolinone are widely used in paint: a multicentre study of paints from five European countries. Contact Dermatitis 72(3):127–138CrossRefPubMedGoogle Scholar
  70. Schwensen JF, Menné T, Friis UF, Johansen JD (2015b) Undisclosed methylisothiazolinone in wet wipes for occupational use causing occupational allergic contact dermatitis in a nurse. Contact Dermatitis 73:182–184CrossRefPubMedGoogle Scholar
  71. Schwensen JF, White IR, Thyssen JP, Menné T, Johansen JD (2015c) Failures in risk assessment and risk management for cosmetic preservatives in Europe and the impact on public health. Contact Dermatitis 73:133–141CrossRefPubMedGoogle Scholar
  72. Schwensen JF, Uter W, Magnus B, Svedman C, Goossens A, Wilkinson M, Giménez Arnau A, Gonçalo M, Andersen KE, Paulsen E, Agner T, Foti C, Aalto-Korte K, Johansen JD (2017a) The epidemic of methylisothiazolinone: a European prospective study. Contact Dermatitis 76:272–279CrossRefPubMedGoogle Scholar
  73. Schwensen JF, Menné Bonefeld C, Zachariae C, Agerbeck C, Petersen TH, Geisler C, Bollmann UE, Bester K, Johansen JD (2017b) Cross-reactivity between methylisothiazolinone, octylisothiazolinone and benzisothiazolinone using a modified local lymph node assay. Br J Dermatol 176:176–183CrossRefPubMedGoogle Scholar
  74. Scientific Committee on Consumer Safety (SCCS). Opinion on methylisothiazolinone (P94) – submission III. Adopted on 15 December 2015, SCCS/1557/15. Available at: http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_178.pdf. Last accessed 1 Aug 2017
  75. Shuster S, Spiro J (1987) Measurement of risk of sensitisation and its application to kathon. Contact Dermatitis 17:299–302CrossRefPubMedGoogle Scholar
  76. Slovak AJ (1980) Contact dermatitis due to benzisothiazolone in a works analytical team. Contact Dermatitis 6:187–190CrossRefPubMedGoogle Scholar
  77. Taran JM, Delaney TA (1997) Allergic contact dermatitis to 1,2-benzisothiazolin-3-one in the carpet industry. Australas J Dermatol 38:42–43CrossRefPubMedGoogle Scholar
  78. The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers (SCCNFP) (2003) Opinion concerning methylisothiazolinone (Colipa No. P94). Adopted on 18 March 2003, SCCNFP/0625/02. Available at: http://ec.europa.eu/health/archive/ph_risk/committees/sccp/documents/out_201.pdf. Accessed 22 May 2018
  79. The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers (SCNNFP) (2004) Opinion Concerning Methylisothiazolinone (Colipa No. P94). Adopted on 23 April 2004, SCCNFP/0805/04. Available at: http://ec.europa.eu/health/ph_risk/committees/sccp/documents/out270_en.pdf. Accessed 22 May 2018
  80. Thomsen AV, Schwensen JF, Bossi R, Banerjee P, Giménez-Arnau E, Lepoittevin JP, Lidén C, Uter W, White IR, Johansen JD (2017) Isothiazolinones are still widely used in paints purchased in five European countries: a follow-up study. Contact DermatitisGoogle Scholar
  81. Thyssen JP, Sederberg-Olsen N, Thomsen JF, Menné T (2006) Contact dermatitis from methylisothiazolinone in a paint factory. Contact Dermatitis 54:322–324CrossRefPubMedGoogle Scholar
  82. Tosti A (1988) Prevalence and sources of Kathon CG sensitization in Italy. Contact Dermatitis 18:173–174CrossRefPubMedGoogle Scholar
  83. Urwin R, Craig S, Latheef F, Wilkinson M (2017) Methylisothiazolinone: the epidemic is declining – but not gone. Contact Dermatitis 76:301–302CrossRefPubMedGoogle Scholar
  84. Uter W, Geier J, Bauer A, Schnuch A (2013) Risk factors associated with methylisothiazolinone contact sensitization. Contact Dermatitis 69:231–238CrossRefPubMedGoogle Scholar
  85. Uter W, Yazar K, Kratz EM, Mildau G, Lidén C (2014) Coupled exposure to ingredients of cosmetic products: II. Preservatives. Contact Dermatitis 70:219–226CrossRefPubMedGoogle Scholar
  86. Uter W, Amario-Hita JC, Balato A, Ballmer-Weber B, Bauer A, Belloni Fortina A, Bircher A, Chowdhury MMU, Cooper SM, Dugonik A, Gallo R, Giménez-Arnau A, Johansen JD, John SM, Kieć-Świerczyńska M, Kmecl T, Kręcisz B, Larese Filon F, Mahler V, Pesonen M, Rustemeyer T, Sadowska-Przytocka A, Sánchez-Perez J, Schliemann S, Schuttelaar ML, Simon D, Spiewak R, Valiukeviciene S, Weisshaar E, White IR, Wilkinson SM (2017) European surveillance system on contact allergies (ESSCA): results with the European baseline series, 2013/14. J Eur Acad Dermatol Venereol.  https://doi.org/10.1111/jdv.14423. [Epub ahead of print]
  87. Vandevenne A, Vanden Broecke K, Goossens A (2014) Sofa dermatitis caused by methylisothiazolinone in a leather-care product. Contact Dermatitis 71(2):111–113CrossRefPubMedGoogle Scholar
  88. Vanneste L, Persson L, Zimerson E, Bruze M, Luyckx R, Goossens A (2013) Allergic contact dermatitis caused by methylisothiazolinone from different sources, including ‘mislabelled’ household wet wipes. Contact Dermatitis 69:311–312CrossRefPubMedGoogle Scholar
  89. Venables ZC, Bourke JF, Buckley DA, Campbell F, Chowdhury MM, Abdul-Ghaffar S, Green C, Holden C R, Mcfadden J, Orton D, Sabroe R A, Sansom J, Stone NM, Wakelin SH, Wilkinson SM, Johnston GA (2016) Has the epidemic of allergic contact dermatitis due to methylisothiazolinone reached its peak? Br J DermatolGoogle Scholar
  90. Wilkinson JD, Shaw S, Andersen KE, Brandao FM, Bruynzeel DP, Bruze M, Camarasa JM, Diepgen TL, Ducombs G, Frosch PJ, Goossens A, Lachappelle JM, Lahti A, Menné T, Seidenari S, Tosti A, Wahlberg JE (2002) Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991–2000). Contact Dermatitis 46:207–210CrossRefPubMedGoogle Scholar
  91. Wilford JE, de Gannes GC (2017) Methylisothiazolinone contact allergy prevalence in Western Canada: increased detection with 2000 ppm patch test allergen. J Cutan Med Surg.  https://doi.org/10.1177/1203475417690307. [Epub ahead of print]
  92. Yazar K, Johnsson S, Lind ML, Boman A, Lidén C (2011) Preservatives and fragrances in selected consumer-available cosmetics and detergents. Contact Dermatitis 64:265–272CrossRefPubMedGoogle Scholar
  93. Yazar K, Lundov MD, Faurschou A, Matura M, Boman A, Johansen JD, Lidén C (2015) Methylisothiazolinone in rinse-off products causes allergic contact dermatitis: a repeated open-application study. Br J Dermatol 173:115–122CrossRefPubMedGoogle Scholar
  94. Zirwas MJ, Hamann D, Warshaw EM, Maibach HI, Taylor JS, Sasseville D, DeKoven JG, Fransway AF, Mathias CGT, Zug KA, DeLeo VA, Fowler JF, Marks JG, Pratt MD, Belsito DV (2017) Epidemic of isothiazolinone allergy in North America: prevalence data from the North American Contact Dermatitis Group, 2013–2014. Dermatitis 28(3):204–209.  https://doi.org/10.1097/DER.0000000000000288CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Jakob Ferløv Schwensen
    • 1
  • Jeanne Duus Johansen
    • 1
  1. 1.National Allergy Research Centre, Department of Dermatology and AllergyCopenhagen University Hospital Herlev-GentofteHellerupDenmark

Personalised recommendations